pharmaceutical industry

7:53 pm
Mon March 17, 2014

Former Upjohn CEO John Zabriskie dies

Lead in text: 
Zabriske led Upjohn in the mid-1990's and is considered the architect of the merger with Swedish drug giant Pharmacia AB
  • Source: Mlive
  • | Via: Kalamazoo Gazette
KALAMAZOO, MI -- John L. Zabriskie Jr., former chairman and chief executive officer of The Upjohn Co., died Thursday at his home in Boulder, Colo., after a bout with throat cancer. He was 74. Zabriskie was chairman and CEO of The Upjohn Co.
8:07 pm
Mon March 3, 2014

Perrigo Acquires New Products to Sell Overseas

Lead in text: 
The products are expected to generate at least $20-million in annual revenue
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI -- Perrigo Co. is expanding its activities overseas with the acquisition of a collection of over-the-counter products sold in Australia and New Zealand and with transactions that modify its involvement with a neuropsychiatric drug being developed in Ireland.
7:19 pm
Mon July 29, 2013

Governor Snyder's office "disappointed" Perrigo to become Irish company

Lead in text: 
Perrigo announced acquisition of Ireland's Elan Pharmaceuticals on Monday
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI - Gov. Rick Snyder's office is disappointed Perrigo Co. will become an Irish company but is not ignoring company plans to continue investing in West Michigan.
7:15 am
Mon July 29, 2013

Perrigo to acquire Irish pharmaceutical company

Lead in text: 
Allegan-based company says deal will allow for international expansion and diversifying global business
Allegan-based generic drug manufacturer Perrigo announced this morning that it agreed to acquire Irish pharmaceutical maker Elan Corp. PLC in a cash-and-stock transaction valued at $8.6 billion.
Read More: http://mibiz.com
11:54 am
Mon February 11, 2013

Perrigo completes acquisition of U.K.-based pharmaceutical company

Lead in text: 
Allegan-based Perrigo says acquiring Rosemont helps expansion into attractive specialty market.
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI -- Perrigo Co. says it signed a definitive merger agreement and has completed the acquisition of Rosemont Pharmaceuticals Ltd. for $283 million in cash. Rosemont is a specialty and generic prescription pharmaceutical company focused on manufacturing and marketing oral liquid formulations. It was founded in 1967 and is based in Leeds in the United Kingdom.